Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA transparency with industry: FDA is collecting information on ways it can improve transparency with regulated industries, the third phase of its ongoing transparency initiative. FDA says it held three listening sessions with members of regulated industry on Jan. 21, 27 and 28 and will publish transcripts of those sessions on the dockets. The agency seeks public comment on issues raised during the meetings and on how it can improve regulatory training and education for industry; guidance development; channels of communication with industry routinely and during crises; useful and timely answers to industry questions; and communications with sponsors during application reviews. Comments are due April 12
You may also be interested in...
J&J/DePuy Recalls ASR Hip Systems - Effort Could Cost $1.2 Bil.
Johnson & Johnson subsidiary DePuy Orthopaedics is recalling all of its ASR hip resurfacing and ASR XL acetabular hip replacement systems worldwide due to elevated rates of revision surgeries to replace the devices, the company said Aug. 26
J&J/DePuy Recalls ASR Hip Systems - Effort Could Cost $1.2 Bil.
Johnson & Johnson subsidiary DePuy Orthopaedics is recalling all of its ASR hip resurfacing and ASR XL acetabular hip replacement systems worldwide due to elevated rates of revision surgeries to replace the devices, the company said Aug. 26
Regulatory News In Brief
Fiscal 2012 budget cuts: White House Office of Management and Budget Director Peter Orszag and White House Chief of Staff Rahm Emanuel are directing federal agencies to find ways to cut their fiscal 2012 budgets by 5%, according to a June 8 1memo and budget 2guidance. Agencies should identify programs "that have the lowest impact on your agency's mission," the memo states. Fiscal 2012 budget submissions are due to OMB by Sept. 13. The Obama administration has pledged to freeze non-security discretionary spending through fiscal 2013